Publications
Selected publications
- Effect of sildenafil on maternal hemodynamics in pregnancies complicated by severe early‐onset fetal growth restriction: planned subgroup analysis from a multicenter randomized placebo‐controlled double‐blind trial (Journal article - 2020)
- Mortality in the UK STRIDER trial of sildenafil therapy for the treatment of severe early-onset fetal growth restriction (Journal article - 2019)
- Maternal sildenafil for severe fetal growth restriction (STRIDER): a multicentre, randomised, placebo-controlled, double-blind trial (Journal article - 2018)
- Dopamine transporter (DAT1/SLC6A3) polymorphism and the association between being born small for gestational age and symptoms of ADHD. (Journal article - 2017)
- Children born small for gestational age are not at special risk for preschool emotion and behaviour problems. (Journal article - 2012)
- Initial evidence that polymorphisms in neurotransmitter-regulating genes contribute to being born small for gestational age. (Journal article - 2012)
- The catechol-O-methyltransferase (COMT) Val158Met polymorphism moderates the effect of antenatal stress on childhood behavioural problems: longitudinal evidence across multiple ages. (Journal article - 2012)
- Stimulant drug effects on attention deficit/hyperactivity disorder: a review of the effects of age and sex of patients. (Journal article - 2010)
- Short-term outcomes of phosphodiesterase type 5 inhibitors for fetal growth restriction: a study protocol for a systematic review with individual participant data meta-analysis, aggregate meta-analysis, and trial sequential analysis (Journal article - 2021)
- Children with neonatal Hypoxic Ischaemic Encephalopathy (HIE) treated with therapeutic hypothermia are not as school ready as their peers. (Journal article - 2021)
2024
Diagnosis and management of selective fetal growth restriction in monochorionic twin pregnancies: A cross-sectional international survey.
Prasad, S., Khalil, A., Kirkham, J. J., Sharp, A., Woolfall, K., Mitchell, T. K., . . . FERN Study Team. (2024). Diagnosis and management of selective fetal growth restriction in monochorionic twin pregnancies: A cross-sectional international survey.. BJOG : an international journal of obstetrics and gynaecology, 131(12), 1684-1693. doi:10.1111/1471-0528.17891
Neurodevelopmental outcomes at 2 years in children who received sildenafil therapy in utero: The STRIDER randomised controlled trial.
Sharp, A., Cornforth, C., Jackson, R., Harrold, J., Turner, M. A., Kenny, L. C., . . . STRIDER group. (2024). Neurodevelopmental outcomes at 2 years in children who received sildenafil therapy in utero: The STRIDER randomised controlled trial.. BJOG : an international journal of obstetrics and gynaecology, 131(12), 1673-1683. doi:10.1111/1471-0528.17888
The efficacy of sildenafil therapy in dismal prognosis early-onset intrauterine growth restriction: the STRIDER RCT
Sharp, A., Cornforth, C., Jackson, R., Harrold, J., Turner, M. A., Kenny, L., . . . Alfirevic, Z. (n.d.). The efficacy of sildenafil therapy in dismal prognosis early-onset intrauterine growth restriction: the STRIDER RCT. Efficacy and Mechanism Evaluation, 1-61. doi:10.3310/wakv3677
FERN: Is it possible to conduct a Randomised controlled trial of Intervention or Expectant Management for Early Onset Selective Fetal Growth Restriction in Monochorionic Twin Pregnancy: protocol for a prospective, mixed methods feasibility study
Sharp, A. (2024). FERN: Is it possible to conduct a Randomised controlled trial of Intervention or Expectant Management for Early Onset Selective Fetal Growth Restriction in Monochorionic Twin Pregnancy: protocol for a prospective, mixed methods feasibility study. BMJ Open.
2022
Parent and Teacher (Dis)Agreement on the Conners Rating Scale: Revised-Long Format
Waldie, K. E., Cornforth, C. M., Mitchell, E. A., Slykerman, R. F., Wall, C., & Thompson, J. M. D. (2022). Parent and Teacher (Dis)Agreement on the Conners Rating Scale: Revised-Long Format. International Journal for Research in Learning Disabilities, 5(2), 36-48. doi:10.28987/ijrld.5.2.36
2021
Short-term outcomes of phosphodiesterase type 5 inhibitors for fetal growth restriction: a study protocol for a systematic review with individual participant data meta-analysis, aggregate meta-analysis, and trial sequential analysis
Liauw, J., Groom, K., Ganzevoort, W., Gluud, C., McKinlay, C. J. D., Sharp, A., . . . von Dadelszen, P. (2021). Short-term outcomes of phosphodiesterase type 5 inhibitors for fetal growth restriction: a study protocol for a systematic review with individual participant data meta-analysis, aggregate meta-analysis, and trial sequential analysis. Systematic Reviews, 10(1). doi:10.1186/s13643-021-01849-5
Use of the PROMIS Mobility score in assessing function in adolescents and adults previously affected by childhood hip disease
Luo, W., Ali, M. S., Limb, R., Cornforth, C., & Perry, D. C. (2021). Use of the PROMIS Mobility score in assessing function in adolescents and adults previously affected by childhood hip disease. BONE & JOINT OPEN, 2(12), 1089-1095. doi:10.1302/2633-1462.212.BJO-2021.0154.R1
Children with neonatal Hypoxic Ischaemic Encephalopathy (HIE) treated with therapeutic hypothermia are not as school ready as their peers.
Edmonds, C. J., Cianfaglione, R., Cornforth, C., & Vollmer, B. (2021). Children with neonatal Hypoxic Ischaemic Encephalopathy (HIE) treated with therapeutic hypothermia are not as school ready as their peers.. Acta paediatrica (Oslo, Norway : 1992), 110(10), 2756-2765. doi:10.1111/apa.16002
Cervical cerclage, pessary, or vaginal progesterone in high-risk pregnant women with short cervix: a randomized feasibility study
Care, A., Jackson, R., O'Brien, E., Leigh, S., Cornforth, C., Haycox, A., . . . Alfirevic, Z. (2021). Cervical cerclage, pessary, or vaginal progesterone in high-risk pregnant women with short cervix: a randomized feasibility study. JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 34(1), 49-57. doi:10.1080/14767058.2019.1588245
2020
The PLANES study: a protocol for a randomised controlled feasibility study of the placental growth factor (PlGF) blood test-informed care versus standard care alone for women with a small for gestational age fetus at or after 32+0weeks' gestation
Gent, J., Bullough, S., Harrold, J., Jackson, R., Woolfall, K., Andronis, L., . . . Sharp, A. (2020). The PLANES study: a protocol for a randomised controlled feasibility study of the placental growth factor (PlGF) blood test-informed care versus standard care alone for women with a small for gestational age fetus at or after 32+0weeks' gestation. PILOT AND FEASIBILITY STUDIES, 6(1). doi:10.1186/s40814-020-00722-x
Effect of sildenafil on maternal hemodynamics in pregnancies complicated by severe early‐onset fetal growth restriction: planned subgroup analysis from a multicenter randomized placebo‐controlled double‐blind trial
Khalil, A., Sharp, A. N., Cornforth, C., Jackson, R., Mousa, H., Stock, S., . . . Alfirevic, Z. (2020). Effect of sildenafil on maternal hemodynamics in pregnancies complicated by severe early‐onset fetal growth restriction: planned subgroup analysis from a multicenter randomized placebo‐controlled double‐blind trial. Ultrasound in Obstetrics and Gynecology, 55(2), 198-209. doi:10.1002/uog.20851
2019
A Prediction Model for Short-Term Neonatal Outcomes in Severe Early-Onset Fetal Growth Restriction
Sharp, A., Jackson, R., Cornforth, C., Harrold, J., Turner, M. A., Kenny, L., . . . Alfirevic, Z. (2019). A Prediction Model for Short-Term Neonatal Outcomes in Severe Early-Onset Fetal Growth Restriction. European Journal of Obstetrics and Gynecology and Reproductive Biology, 241, 109-118. doi:10.1016/j.ejogrb.2019.08.007
Learning from the STRIDER trial
Sharp, A., Cornforth, C., & Alfirevic, Z. (2019). Learning from the STRIDER trial. Obstetrics, Gynaecology & Reproductive Medicine, 29(8), 240-241. doi:10.1016/j.ogrm.2019.04.011
Mortality in the UK STRIDER trial of sildenafil therapy for the treatment of severe early-onset fetal growth restriction
Sharp, A., Cornforth, C., Jackson, R., Harrold, J., Turner, M. A., Kenny, L., . . . Alfirevic, Z. (2019). Mortality in the UK STRIDER trial of sildenafil therapy for the treatment of severe early-onset fetal growth restriction. LANCET CHILD & ADOLESCENT HEALTH, 3(3), E2-E3. doi:10.1016/S2352-4642(19)30020-3
2018
81. Maternal cardiovascular changes secondary to sildenafil intake in pregnancies complicated by severe fetal growth restriction: STRIDER trial
Khalil, A., Sharp, A., Cornforth, C., Jackson, R., Mousa, H., Stock, S., . . . Alfirevic, Z. (2018). 81. Maternal cardiovascular changes secondary to sildenafil intake in pregnancies complicated by severe fetal growth restriction: STRIDER trial. Pregnancy Hypertension, 13, S70. doi:10.1016/j.preghy.2018.08.207
OP19.10: Maternal cardiovascular changes secondary to sildenafil intake in pregnancies complicated by severe fetal growth restriction: STRIDER trial
Khalil, A., Sharp, A., Cornforth, C., Jackson, R., Mousa, H., Stock, S., . . . Alfirevic, Z. (2018). OP19.10: Maternal cardiovascular changes secondary to sildenafil intake in pregnancies complicated by severe fetal growth restriction: STRIDER trial. Ultrasound in Obstetrics & Gynecology, 52(S1), 125. doi:10.1002/uog.19574
Maternal sildenafil for severe fetal growth restriction (STRIDER): a multicentre, randomised, placebo-controlled, double-blind trial
Sharp, A., Cornforth, C., Turner, M. A., Harrold, J., Kenny, L. C., Jackson, R., . . . Alfirevic, Z. (2018). Maternal sildenafil for severe fetal growth restriction (STRIDER): a multicentre, randomised, placebo-controlled, double-blind trial. Lancet Child and Adolescent Health, 2(2), 93-102. doi:10.1016/S2352-4642(17)30173-6
2017
Dopamine transporter (DAT1/SLC6A3) polymorphism and the association between being born small for gestational age and symptoms of ADHD.
Waldie, K. E., Cornforth, C. M., Webb, R. E., Thompson, J. M. D., Murphy, R., Moreau, D., . . . Mitchell, E. A. (2017). Dopamine transporter (<i>DAT1</i>/<i>SLC6A3</i>) polymorphism and the association between being born small for gestational age and symptoms of ADHD. BEHAVIOURAL BRAIN RESEARCH, 333, 90-97. doi:10.1016/j.bbr.2017.06.040
2012
Children born small for gestational age are not at special risk for preschool emotion and behaviour problems.
Cornforth, C. M., Thompson, J. M. D., Robinson, E., Waldie, K. E., Pryor, J. E., Clark, P., . . . Mitchell, E. A. (2012). Children born small for gestational age are not at special risk for preschool emotion and behaviour problems.. Early human development, 88(7), 479-485. doi:10.1016/j.earlhumdev.2011.12.001
The catechol-O-methyltransferase (COMT) Val158Met polymorphism moderates the effect of antenatal stress on childhood behavioural problems: longitudinal evidence across multiple ages.
Thompson, J. M. D., Sonuga-Barke, E. J., Morgan, A. R., Cornforth, C. M., Turic, D., Ferguson, L. R., . . . Waldie, K. E. (2012). The catechol-O-methyltransferase (COMT) Val158Met polymorphism moderates the effect of antenatal stress on childhood behavioural problems: longitudinal evidence across multiple ages.. Developmental medicine and child neurology, 54(2), 148-154. doi:10.1111/j.1469-8749.2011.04129.x
Initial evidence that polymorphisms in neurotransmitter-regulating genes contribute to being born small for gestational age.
Morgan, A. R., Thompson, J. M. D., Waldie, K. E., Cornforth, C. M., Turic, D., Sonuga-Barke, E. J. S., . . . Mitchell, E. A. (2012). Initial evidence that polymorphisms in neurotransmitter-regulating genes contribute to being born small for gestational age.. Journal of pediatric genetics, 1(2), 103-113. doi:10.3233/pge-2012-018
2010
Stimulant drug effects on attention deficit/hyperactivity disorder: a review of the effects of age and sex of patients.
Cornforth, C., Sonuga-Barke, E., & Coghill, D. (2010). Stimulant drug effects on attention deficit/hyperactivity disorder: a review of the effects of age and sex of patients.. Current pharmaceutical design, 16(22), 2424-2433. doi:10.2174/138161210791959827